| 摘要 |
This invention relates to M3 antagonists of formula (I) wherein R2, R4, R 5, R6, W, V, A, D, X, t, u and v are as defined herein; pharmaceutical compo sitions containing them; methods for their preparation; and their use in the treatment of diseases where enhanced M3 receptor activation is implicated.
|
